Home > Insider Trading > Filing (0000899243-21-031104)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1841387	Candel Therapeutics Inc.	CADL	Biological Products, (No Disgnostic Substances) (2836)	522214851

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1873465	Christopher Martell	C/O Candel Therapeutics, Inc. 117 Kendrick St., Suite 450 Needham MA 02494		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-07-29	283,514	$0.00	283,514	No	4	C	Indirect	By GTAM1 2012 ADV LLC
Common Stock	Acquisiton	2021-07-29	125,000	$8.00	125,000	No	4	P	Indirect	By GTAM1 2012 LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	By GTAM1 2012 ADV LLC
No	4	P	Indirect	By GTAM1 2012 LLC

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2021-07-29	696,851	$0.00	283,514	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect

Footnotes

These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date.
Shares held by GTAM1 2012 ADV LLC, for which the Reporting Person serves as manager. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
Shares held by GTAM1 2012 LLC, which is wholly owned by a trust for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.